<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;fc=20230708114047
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;fc=20230708114047" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Sat, 01 Mar 2025 06:14:52 +0000</lastbuilddate>
<pubDate>Fri, 28 Feb 2025 06:00:00 -0500</pubDate>
<ttl>120</ttl>
<item>
<title>Strengthening Global Partnerships to Combat Cardiovascular Disease: A Call to Action</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40019449/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Feb 19:S0735-1097(25)00203-7. doi: 10.1016/j.jacc.2025.01.019. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40019449/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40019449</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.01.019>10.1016/j.jacc.2025.01.019</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40019449</guid>
<pubDate>Fri, 28 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Cathleen Biga</dc:creator>
<dc:creator>Jagat Narula</dc:creator>
<dc:date>2025-02-28</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Strengthening Global Partnerships to Combat Cardiovascular Disease: A Call to Action</dc:title>
<dc:identifier>pmid:40019449</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.01.019</dc:identifier>
</item>
<item>
<title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40019276/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Dec 3;150(23):1898-1903. doi: 10.1161/CIRCULATIONAHA.124.072974. Epub 2024 Dec 2.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40019276/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40019276</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072974>10.1161/CIRCULATIONAHA.124.072974</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40019276</guid>
<pubDate>Fri, 28 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-28</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the &lt;em>;Circulation&lt;/em>; Family of Journals</dc:title>
<dc:identifier>pmid:40019276</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072974</dc:identifier>
</item>
<item>
<title>Better Late Than Early? The Role of the Vascular Endothelium in Late-Onset Menopause</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40014681/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Feb 28;136(5):470-472. doi: 10.1161/CIRCRESAHA.125.326197. Epub 2025 Feb 27.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40014681/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40014681</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.125.326197>10.1161/CIRCRESAHA.125.326197</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40014681</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Gurleen Kaur</dc:creator>
<dc:creator>Naomi M Hamburg</dc:creator>
<dc:creator>Emily S Lau</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Better Late Than Early? The Role of the Vascular Endothelium in Late-Onset Menopause</dc:title>
<dc:identifier>pmid:40014681</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.125.326197</dc:identifier>
</item>
<item>
<title>Roles of Sirtuins in Cardiovascular Diseases: Mechanisms and Therapeutics</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40014680/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>Cardiovascular diseases (CVDs) are experiencing a rapid surge and are widely recognized as the leading cause of mortality in the current aging society. Given the multifactorial etiology of CVDs, understanding the intricate molecular and cellular mechanisms is imperative. Over the past 2 decades, many scientists have focused on Sirtuins, a family of nicotinamide adenine dinucleotide-dependent deacylases. Sirtuins are highly conserved across species, from yeasts to primates, and play a crucial...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Feb 28;136(5):524-550. doi: 10.1161/CIRCRESAHA.124.325440. Epub 2025 Feb 27.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Cardiovascular diseases (CVDs) are experiencing a rapid surge and are widely recognized as the leading cause of mortality in the current aging society. Given the multifactorial etiology of CVDs, understanding the intricate molecular and cellular mechanisms is imperative. Over the past 2 decades, many scientists have focused on Sirtuins, a family of nicotinamide adenine dinucleotide-dependent deacylases. Sirtuins are highly conserved across species, from yeasts to primates, and play a crucial role in linking aging and diseases. Sirtuins participate in nearly all key physiological and pathological processes, ranging from embryogenic development to stress response and aging. Abnormal expression and activity of Sirtuins exist in many aging-related diseases, while their activation has shown efficacy in mitigating these diseases (eg, CVDs). In terms of research, this field has maintained fast, sustained growth in recent years, from fundamental studies to clinical trials. In this review, we present a comprehensive, up-to-date discussion on the biological functions of Sirtuins and their roles in regulating cardiovascular biology and CVDs. Furthermore, we highlight the latest advancements in utilizing Sirtuin-activating compounds and nicotinamide adenine dinucleotide boosters as potential pharmacological targets for preventing and treating CVDs. The key unresolved issues in the field-from the chemicobiological regulation of Sirtuins to Sirtuin-targeted CVD investigations-are also discussed. This timely review could be critical in understanding the updated knowledge of Sirtuin biology in CVDs and facilitating the clinical accessibility of Sirtuin-targeting interventions.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40014680/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40014680</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.325440>10.1161/CIRCRESAHA.124.325440</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40014680</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Yang-Nan Ding</dc:creator>
<dc:creator>Hui-Yu Wang</dc:creator>
<dc:creator>Xiao-Feng Chen</dc:creator>
<dc:creator>Xiaoqiang Tang</dc:creator>
<dc:creator>Hou-Zao Chen</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Roles of Sirtuins in Cardiovascular Diseases: Mechanisms and Therapeutics</dc:title>
<dc:identifier>pmid:40014680</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.325440</dc:identifier>
</item>
<item>
<title>Meet the First Authors</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40014679/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Feb 28;136(5):453-454. doi: 10.1161/RES.0000000000000710. Epub 2025 Feb 27.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40014679/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40014679</a> | DOI:<a href=https://doi.org/10.1161/RES.0000000000000710>10.1161/RES.0000000000000710</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40014679</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-27</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Meet the First Authors</dc:title>
<dc:identifier>pmid:40014679</dc:identifier>
<dc:identifier>doi:10.1161/RES.0000000000000710</dc:identifier>
</item>
<item>
<title>2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40014670/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>AIM: The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" incorporates new evidence since the "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction" and the corresponding "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes" and the "2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction."...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Feb 27. doi: 10.1161/CIR.0000000000001309. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" incorporates new evidence since the "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction" and the corresponding "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes" and the "2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction." The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" and the "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization" retire and replace, respectively, the "2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease."</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A comprehensive literature search was conducted from July 2023 to April 2024. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STRUCTURE: Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40014670/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40014670</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001309>10.1161/CIR.0000000000001309</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40014670</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Sunil V Rao</dc:creator>
<dc:creator>Michelle L O'Donoghue</dc:creator>
<dc:creator>Marc Ruel</dc:creator>
<dc:creator>Tanveer Rab</dc:creator>
<dc:creator>Jaqueline E Tamis-Holland</dc:creator>
<dc:creator>John H Alexander</dc:creator>
<dc:creator>Usman Baber</dc:creator>
<dc:creator>Heather Baker</dc:creator>
<dc:creator>Mauricio G Cohen</dc:creator>
<dc:creator>Mercedes Cruz-Ruiz</dc:creator>
<dc:creator>Leslie L Davis</dc:creator>
<dc:creator>James A de Lemos</dc:creator>
<dc:creator>Tracy A DeWald</dc:creator>
<dc:creator>Islam Y Elgendy</dc:creator>
<dc:creator>Dmitriy N Feldman</dc:creator>
<dc:creator>Abhinav Goyal</dc:creator>
<dc:creator>Ijeoma Isiadinso</dc:creator>
<dc:creator>Venu Menon</dc:creator>
<dc:creator>David A Morrow</dc:creator>
<dc:creator>Debabrata Mukherjee</dc:creator>
<dc:creator>Elke Platz</dc:creator>
<dc:creator>Susan B Promes</dc:creator>
<dc:creator>Sigrid Sandner</dc:creator>
<dc:creator>Yader Sandoval</dc:creator>
<dc:creator>Rachel Schunder</dc:creator>
<dc:creator>Binita Shah</dc:creator>
<dc:creator>Jason P Stopyra</dc:creator>
<dc:creator>Amy W Talbot</dc:creator>
<dc:creator>Pam R Taub</dc:creator>
<dc:creator>Marlene S Williams</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:40014670</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001309</dc:identifier>
</item>
<item>
<title>2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40013746/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>AIM: The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" incorporates new evidence since the "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction" and the corresponding "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes" and the "2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction."...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Feb 27:S0735-1097(24)10424-X. doi: 10.1016/j.jacc.2024.11.009. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">AIM: The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" incorporates new evidence since the "2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction" and the corresponding "2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes" and the "2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction." The "2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes" and the "2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization" retire and replace, respectively, the "2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease."</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: A comprehensive literature search was conducted from July 2023 to April 2024. Clinical studies, systematic reviews and meta-analyses, and other evidence conducted on human participants were identified that were published in English from MEDLINE (through PubMed), EMBASE, the Cochrane Library, Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">STRUCTURE: Many recommendations from previously published guidelines have been updated with new evidence, and new recommendations have been created when supported by published data.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40013746/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40013746</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.11.009>10.1016/j.jacc.2024.11.009</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40013746</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Sunil V Rao</dc:creator>
<dc:creator>Michelle L O'Donoghue</dc:creator>
<dc:creator>Marc Ruel</dc:creator>
<dc:creator>Tanveer Rab</dc:creator>
<dc:creator>Jaqueline E Tamis-Holland</dc:creator>
<dc:creator>John H Alexander</dc:creator>
<dc:creator>Usman Baber</dc:creator>
<dc:creator>Heather Baker</dc:creator>
<dc:creator>Mauricio G Cohen</dc:creator>
<dc:creator>Mercedes Cruz-Ruiz</dc:creator>
<dc:creator>Leslie L Davis</dc:creator>
<dc:creator>James A de Lemos</dc:creator>
<dc:creator>Tracy A DeWald</dc:creator>
<dc:creator>Islam Y Elgendy</dc:creator>
<dc:creator>Dmitriy N Feldman</dc:creator>
<dc:creator>Abhinav Goyal</dc:creator>
<dc:creator>Ijeoma Isiadinso</dc:creator>
<dc:creator>Venu Menon</dc:creator>
<dc:creator>David A Morrow</dc:creator>
<dc:creator>Debabrata Mukherjee</dc:creator>
<dc:creator>Elke Platz</dc:creator>
<dc:creator>Susan B Promes</dc:creator>
<dc:creator>Sigrid Sandner</dc:creator>
<dc:creator>Yader Sandoval</dc:creator>
<dc:creator>Rachel Schunder</dc:creator>
<dc:creator>Binita Shah</dc:creator>
<dc:creator>Jason P Stopyra</dc:creator>
<dc:creator>Amy W Talbot</dc:creator>
<dc:creator>Pam R Taub</dc:creator>
<dc:creator>Marlene S Williams</dc:creator>
<dc:creator>Peer Review Committee Members</dc:creator>
<dc:creator>Hani Jneid</dc:creator>
<dc:creator>Craig J Beavers</dc:creator>
<dc:creator>Faisal M Merchant</dc:creator>
<dc:creator>Theresa Beckie</dc:creator>
<dc:creator>Noreen Nazir</dc:creator>
<dc:creator>Jim Blankenship</dc:creator>
<dc:creator>Derek So</dc:creator>
<dc:creator>Deborah Diercks</dc:creator>
<dc:creator>Matthew Tomey</dc:creator>
<dc:creator>Bruce Lo</dc:creator>
<dc:creator>Frederick Welt</dc:creator>
<dc:creator>Clauden Louis</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:40013746</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.11.009</dc:identifier>
</item>
<item>
<title>2025 Acute Coronary Syndromes Guideline-at-a-Glance</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40013745/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Feb 27:S0735-1097(25)00202-5. doi: 10.1016/j.jacc.2025.01.018. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40013745/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40013745</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.01.018>10.1016/j.jacc.2025.01.018</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40013745</guid>
<pubDate>Thu, 27 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Dharam J Kumbhani</dc:creator>
<dc:creator>Morgane Cibotti-Sun</dc:creator>
<dc:creator>Mykela M Moore</dc:creator>
<dc:date>2025-02-27</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>2025 Acute Coronary Syndromes Guideline-at-a-Glance</dc:title>
<dc:identifier>pmid:40013745</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.01.018</dc:identifier>
</item>
<item>
<title>Endomyocardial fibrosis: recent advances and future therapeutic targets</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40011660/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>Endomyocardial fibrosis, first described >;75 years ago, is a cause of restrictive cardiomyopathy with an unclear aetiopathogenesis that is most commonly found in children and adolescents from tropical regions of Africa, Asia and South America. The epidemiological trends of this cardiomyopathy are difficult to ascertain. The characteristic hallmark of endomyocardial fibrosis is ventricular fibrosis that causes diastolic dysfunction and atrioventricular regurgitation. Although advances in medical...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Feb 26. doi: 10.1038/s41569-025-01138-x. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Endomyocardial fibrosis, first described >;75 years ago, is a cause of restrictive cardiomyopathy with an unclear aetiopathogenesis that is most commonly found in children and adolescents from tropical regions of Africa, Asia and South America. The epidemiological trends of this cardiomyopathy are difficult to ascertain. The characteristic hallmark of endomyocardial fibrosis is ventricular fibrosis that causes diastolic dysfunction and atrioventricular regurgitation. Although advances in medical treatment for heart failure and more tailored surgical techniques to treat the condition have increased survival, the outcomes in affected patients remain poor. A major focus of research is the identification of biomarkers of preclinical disease and new therapeutic targets. Collaborative multidisciplinary research and cross-learning from other fibrotic conditions should impart knowledge and help to improve the survival rates and the quality of life of patients with endomyocardial fibrosis.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40011660/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40011660</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01138-x>10.1038/s41569-025-01138-x</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40011660</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Ana O Mocumbi</dc:creator>
<dc:creator>Viviane Tiemi Hotta</dc:creator>
<dc:creator>Gene Bukhman</dc:creator>
<dc:creator>Ntobeko Ntusi</dc:creator>
<dc:creator>Magdi H Yacoub</dc:creator>
<dc:creator>Paulo Correia-de-Sá</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Endomyocardial fibrosis: recent advances and future therapeutic targets</dc:title>
<dc:identifier>pmid:40011660</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01138-x</dc:identifier>
</item>
<item>
<title>The Dynamic Equilibrium of Heart Valve Transplantation: A Balance of Similarities and Differences</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40010932/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Mar 4;85(8):870-872. doi: 10.1016/j.jacc.2025.01.012.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40010932/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40010932</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.01.012>10.1016/j.jacc.2025.01.012</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40010932</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Emily A Downs</dc:creator>
<dc:creator>Melanie D Everitt</dc:creator>
<dc:creator>Matthew L Stone</dc:creator>
<dc:creator>Shelley D Miyamoto</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>The Dynamic Equilibrium of Heart Valve Transplantation: A Balance of Similarities and Differences</dc:title>
<dc:identifier>pmid:40010932</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.01.012</dc:identifier>
</item>
<item>
<title>Domino Heart Valve Transplant in Children With Congenital Valve Disease: Short-Term Outcomes, Growth, and Immunosensitization</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40010931/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Mar 4;85(8):866-869. doi: 10.1016/j.jacc.2024.12.008.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40010931/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40010931</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2024.12.008>10.1016/j.jacc.2024.12.008</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40010931</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>David M Kalfa</dc:creator>
<dc:creator>Marc Richmond</dc:creator>
<dc:creator>Elizabeth M Cordoves</dc:creator>
<dc:creator>Teresa Lee</dc:creator>
<dc:creator>Warren Zuckerman</dc:creator>
<dc:creator>Stephan Juergensen</dc:creator>
<dc:creator>Amee Shah</dc:creator>
<dc:creator>Emile A Bacha</dc:creator>
<dc:creator>Andrew B Goldstone</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>Domino Heart Valve Transplant in Children With Congenital Valve Disease: Short-Term Outcomes, Growth, and Immunosensitization</dc:title>
<dc:identifier>pmid:40010931</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2024.12.008</dc:identifier>
</item>
<item>
<title>The Essential Role of Cardiovascular Surgery in Cardiology: A Perspective From JACC</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40010930/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">J Am Coll Cardiol. 2025 Mar 4;85(8):785-787. doi: 10.1016/j.jacc.2025.01.016.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40010930/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40010930</a> | DOI:<a href=https://doi.org/10.1016/j.jacc.2025.01.016>10.1016/j.jacc.2025.01.016</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40010930</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Harlan M Krumholz</dc:creator>
<dc:creator>Makoto Mori</dc:creator>
<dc:creator>Arnar Geirsson</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>Journal of the American College of Cardiology</dc:source>
<dc:title>The Essential Role of Cardiovascular Surgery in Cardiology: A Perspective From JACC</dc:title>
<dc:identifier>pmid:40010930</dc:identifier>
<dc:identifier>doi:10.1016/j.jacc.2025.01.016</dc:identifier>
</item>
<item>
<title>Highlights From the Circulation Family of Journals</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009738/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 29;150(18):1469-1474. doi: 10.1161/CIRCULATIONAHA.124.072348. Epub 2024 Oct 28.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009738/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40009738</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072348>10.1161/CIRCULATIONAHA.124.072348</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009738</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-26</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Highlights From the Circulation Family of Journals</dc:title>
<dc:identifier>pmid:40009738</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072348</dc:identifier>
</item>
<item>
<title>Error in Results</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009404/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26:e250076. doi: 10.1001/jamacardio.2025.0076. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009404/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40009404</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11866062/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">PMC11866062</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2025.0076>10.1001/jamacardio.2025.0076</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009404</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Error in Results</dc:title>
<dc:identifier>pmid:40009404</dc:identifier>
<dc:identifier>pmc:PMC11866062</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2025.0076</dc:identifier>
</item>
<item>
<title>What Counts for Worsening Heart Failure Events</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009376/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2025.0042. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009376/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40009376</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2025.0042>10.1001/jamacardio.2025.0042</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009376</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Gregg C Fonarow</dc:creator>
<dc:creator>Adrian F Hernandez</dc:creator>
<dc:creator>James E Udelson</dc:creator>
<dc:creator>Clyde W Yancy</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>What Counts for Worsening Heart Failure Events</dc:title>
<dc:identifier>pmid:40009376</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2025.0042</dc:identifier>
</item>
<item>
<title>Balancing Concerns-AI and Moral Agency in Medicine</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009375/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2024.5696. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009375/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40009375</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.5696>10.1001/jamacardio.2024.5696</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009375</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Somogy Varga</dc:creator>
<dc:creator>Asbjørn Steglich-Petersen</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Balancing Concerns-AI and Moral Agency in Medicine</dc:title>
<dc:identifier>pmid:40009375</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.5696</dc:identifier>
</item>
<item>
<title>Balancing Concerns-AI and Moral Agency in Medicine-Reply</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009374/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2024.5699. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009374/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40009374</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.5699>10.1001/jamacardio.2024.5699</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009374</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Sarah C Hull</dc:creator>
<dc:creator>Joseph J Fins</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Balancing Concerns-AI and Moral Agency in Medicine-Reply</dc:title>
<dc:identifier>pmid:40009374</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.5699</dc:identifier>
</item>
<item>
<title>Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009358/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS AND RELEVANCE: Outpatient worsening HF events requiring oral diuretic intensification were common, associated with poor prognosis, and reduced by finerenone in patients with HF with mildly reduced or preserved ejection fraction.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26:e250016. doi: 10.1001/jamacardio.2025.0016. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">IMPORTANCE: Worsening heart failure (HF) is commonly managed in the outpatient setting with adjustments in oral diuretic therapy. The effect of the nonsteroidal mineralocorticoid receptor antagonist finerenone on outpatient worsening HF events in patients with mildly reduced or preserved ejection fraction is unknown.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">OBJECTIVE: To evaluate the effect of finerenone on outpatient worsening HF events requiring oral diuretic intensification among patients with HF with mildly reduced or preserved ejection fraction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">DESIGN, SETTING, AND PARTICIPANTS: This is a secondary analysis of the Finerenone Trial to Investigate Efficacy and Safety Superior to Placebo in Patients With Heart Failure (FINEARTS-HF), a global, multicenter randomized clinical trial. Patients had HF and an ejection fraction of 40% or greater. Data analysis was conducted from September 1 to December 10, 2024.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">INTERVENTION: Participants were randomized 1:1 to finerenone or placebo.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">MAIN OUTCOMES AND MEASURES: Primary outcome events (cardiovascular death, HF hospitalization, and outpatient urgent HF visit requiring intravenous diuretic therapy) were centrally adjudicated. In this prespecified analysis, outpatient oral diuretic intensification events were defined as initiations of loop or thiazide diuretic or increases in loop diuretic dosage. The risk of all-cause death following each type of worsening HF event (HF hospitalization, urgent HF visit, or outpatient oral diuretic intensification) and the effect of finerenone on outpatient oral diuretic intensification alone or as part of an extended composite outcome with primary outcome events were evaluated.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A total of 6001 participants (mean [SD] age, 72.0 [9.6] years; 2732 [46%] female) were enrolled. First worsening HF events included 664 HF hospitalizations, 87 urgent HF visits, and 1250 oral diuretic intensifications. Rates of death were higher following worsening HF: 27.7 (95% CI, 24.3-31.5) per 100 patient-years after HF hospitalization, 13.6 (95% CI, 8.8-21.1) per 100 patient-years after urgent HF visit, and 11.6 (95% CI, 10.2-13.1) per 100 patient-years after outpatient oral diuretic intensification compared with 4.5 (95% CI, 4.2-4.9) per 100 patient-years for patients without worsening HF. Adding outpatient oral diuretic intensification to the primary outcome increased the number of patients experiencing events from 1343 to 2238. Finerenone reduced outpatient oral diuretic intensification alone (hazard ratio [HR], 0.89 [95% CI, 0.80-0.98]; P = .02) and in an extended composite outcome that further included cardiovascular death, HF hospitalization, and urgent HF visit (HR, 0.85 [95% CI, 0.78-0.92]; P &lt; .001).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS AND RELEVANCE: Outpatient worsening HF events requiring oral diuretic intensification were common, associated with poor prognosis, and reduced by finerenone in patients with HF with mildly reduced or preserved ejection fraction.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT04435626.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009358/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40009358</a> | PMC:<a href="https://www.ncbi.nlm.nih.gov/pmc/PMC11866067/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">PMC11866067</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2025.0016>10.1001/jamacardio.2025.0016</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009358</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Jonathan W Cunningham</dc:creator>
<dc:creator>Safia Chatur</dc:creator>
<dc:creator>Brian L Claggett</dc:creator>
<dc:creator>Muthiah Vaduganathan</dc:creator>
<dc:creator>Akshay S Desai</dc:creator>
<dc:creator>Pardeep S Jhund</dc:creator>
<dc:creator>Guillermo Llamas Esperón</dc:creator>
<dc:creator>Carolyn S P Lam</dc:creator>
<dc:creator>Naoki Sato</dc:creator>
<dc:creator>Michele Senni</dc:creator>
<dc:creator>Sanjiv Shah</dc:creator>
<dc:creator>Adriaan Voors</dc:creator>
<dc:creator>Faiez Zannad</dc:creator>
<dc:creator>Bertram Pitt</dc:creator>
<dc:creator>Shelley Zieroth</dc:creator>
<dc:creator>Meike Brinker</dc:creator>
<dc:creator>Katja Rohwedder</dc:creator>
<dc:creator>So-Young Kim</dc:creator>
<dc:creator>James Lay-Flurrie</dc:creator>
<dc:creator>Prabhakar Viswanathan</dc:creator>
<dc:creator>John J V McMurray</dc:creator>
<dc:creator>Scott D Solomon</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>Finerenone and Outpatient Worsening Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial</dc:title>
<dc:identifier>pmid:40009358</dc:identifier>
<dc:identifier>pmc:PMC11866067</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2025.0016</dc:identifier>
</item>
<item>
<title>New Right Atrial Image After Coronary Revascularization Surgery</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40009357/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">JAMA Cardiol. 2025 Feb 26. doi: 10.1001/jamacardio.2024.5690. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40009357/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">40009357</a> | DOI:<a href=https://doi.org/10.1001/jamacardio.2024.5690>10.1001/jamacardio.2024.5690</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40009357</guid>
<pubDate>Wed, 26 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Clara Nuevo-Gallardo</dc:creator>
<dc:creator>María Reyes González-Fernández</dc:creator>
<dc:creator>María Yuste-Domínguez</dc:creator>
<dc:date>2025-02-26</dc:date>
<dc:source>JAMA cardiology</dc:source>
<dc:title>New Right Atrial Image After Coronary Revascularization Surgery</dc:title>
<dc:identifier>pmid:40009357</dc:identifier>
<dc:identifier>doi:10.1001/jamacardio.2024.5690</dc:identifier>
</item>
<item>
<title>Suspected heart failure: a clinical pattern that calls for action</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39999002/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehae846. doi: 10.1093/eurheartj/ehae846. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39999002/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">39999002</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae846>10.1093/eurheartj/ehae846</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39999002</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Stefan Störk</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Suspected heart failure: a clinical pattern that calls for action</dc:title>
<dc:identifier>pmid:39999002</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae846</dc:identifier>
</item>
<item>
<title>Three strikes in a row: a challenging case of carcinoid syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39998470/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250301011450&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Feb 25:ehaf087. doi: 10.1093/eurheartj/ehaf087. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39998470/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250301011450&v=2.18.0.post9+e462414">39998470</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf087>10.1093/eurheartj/ehaf087</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39998470</guid>
<pubDate>Tue, 25 Feb 2025 06:00:00 -0500</pubDate>
<dc:creator>Giuseppe Bruschi</dc:creator>
<dc:creator>Igor Belluschi</dc:creator>
<dc:creator>Claudio F Russo</dc:creator>
<dc:date>2025-02-25</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Three strikes in a row: a challenging case of carcinoid syndrome</dc:title>
<dc:identifier>pmid:39998470</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf087</dc:identifier>
</item>





























</channel>
</rss>